Owlet Secures $9 Million in Strategic Financing to Propel Its Smart Infant Monitoring Tech Forward
Feb 26, 2024•almost 2 years ago
Amount Raised
$9 Million
Round Type
series b
Investors
Not Mentioned
Description
Owlet, Inc. has secured $9 million through the sale of its Series B convertible preferred stock and warrants, marking a pivotal moment in its journey towards global commercialization and profitability. The financing is aimed at accelerating Owlet's momentum after recent FDA clearance of new medical devices and encouraging preliminary results for the fourth quarter.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers